FDA Approves First 12-Month Injectable Flea and Tick Treatment for Dogs | MRK Stock News

TL;DR


Summary:
- The FDA has approved Bravecto Quantum, a new extended-release treatment for flea and tick control in dogs.
- Bravecto Quantum contains the active ingredient fluralaner, which provides up to 12 weeks of protection against fleas and ticks in a single dose.
- This new formulation offers a convenient and long-lasting solution for pet owners to keep their dogs protected from these common parasites.

Like summarized versions? Support us on Patreon!